SCHEDULE: Woodline Partners Discloses 5.9% Stake in Equillium
Beneficial Ownership Report (Schedule 13G)
Woodline Partners LP has reported a 5.9% beneficial ownership stake in Equillium, Inc., holding 3,508,771 shares of common stock.
Summary
- Woodline Partners LP, a Delaware limited partnership and investment adviser to Woodline Master Fund LP, has filed a Schedule 13G.
- The filing reports beneficial ownership of 3,508,771 shares of Common Stock in Equillium, Inc.
- This represents 5.9% of Equillium, Inc.'s outstanding Common Stock.
- Woodline Partners LP holds sole voting power and sole dispositive power over all 3,508,771 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Equillium, Inc.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership, inherently neutral in sentiment. It does not convey positive or negative operational news for the issuer.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding Equillium, Inc.'s future performance or Woodline Partners LP's investment strategy beyond the passive nature of the current holding.
Management Comments
- Woodline Partners LP certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of Equillium, Inc.
Industry Context
This filing indicates an institutional investor, Woodline Partners LP, has taken a significant passive stake in Equillium, Inc., a common occurrence in the biotechnology or pharmaceutical sector where specialized funds invest in companies with promising pipelines or technologies.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor taking a passive stake may be viewed positively by some shareholders as an endorsement of the company's value, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 08/12/2025 | Date as of which 59,503,223 shares of Common Stock were outstanding, used for percentage calculation, as reported in Equillium's Form 10-Q. |
| 08/14/2025 | Date Equillium, Inc. filed its Quarterly Report on Form 10-Q for the period ended June 30, 2025. |
| 09/30/2025 | Date of event which requires the filing of this statement. |
| 11/14/2025 | Signature date of the Schedule 13G filing by Woodline Partners LP. |
Keywords
Equillium Inc., Woodline Partners LP, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.